Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocCheck AGXTER:AJ91 71 Operating Margin % is 16.91% as of Dec. 2025, which is 21% above its 10-year median of 13.98. GuruFocus rates XTER:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.52 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 663 Healthcare Providers & Services companies, DocCheck AG ranks better than 83.56% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. DocCheck AG's Operating Income for the
six
months ended in Dec. 2025 was €4.87 Mil. DocCheck AG's Revenue for the
six
months ended in Dec. 2025 was €28.77 Mil. Therefore, DocCheck AG's Operating Margin % for the quarter that ended in Dec. 2025 was 16.91%.
Warning Sign:
DocCheck AG operating margin has been in a 5-year decline. The average rate of decline per year is -10.3%.
The historical rank and industry rank for DocCheck AG's Operating Margin % or its related term are showing as below:
XTER:AJ91'
s Operating Margin % Range Over the Past 10 Years
Min: 5.94 Med: 13.98 Max: 21.17
Current: 15.87
XTER:AJ91's Operating Margin % is ranked better than 83.56% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 4.86
vs XTER:AJ91: 15.87
DocCheck AG's 5-Year Average Operating Margin % Growth Rate was -10.30% per year.
DocCheck AG's Operating Income for the
six
months ended in Dec. 2025 was €4.87 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €8.78 Mil.
DocCheck AG (XTER:AJ91) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
DocCheck AG Operating Margin % Related Terms
DocCheck AG Operating Margin % Historical Data
* Premium members only.
The historical data trend for DocCheck AG's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:AJ91 vs VEEV, BTSG, TEM: Operating Margin % Comparison
For the Health Information Services subindustry, DocCheck AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocCheck AG Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's Operating Margin % distribution charts can be found below:
* The bar in red indicates where DocCheck AG's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
DocCheck AG's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocCheck AG (XTER:AJ91) has a Operating Margin % of 16.91% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on DocCheck AG and its competitors. This is 21% above median its historical median of 13.98. Over the past decade, DocCheck AG's Operating Margin % has ranged from 5.94 to 21.17. According to the industry distribution chart, DocCheck AG ranks #109 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 16.4%.
Is DocCheck AG's Operating Margin % too high?
DocCheck AG's current Operating Margin % of 16.91% is 21% above median its 10-year median of 13.98. Over the past 10 years, this metric has ranged from a low of 5.94 to a high of 21.17. The Healthcare Providers & Services industry median Operating Margin % is 4.86. DocCheck AG's value of 16.91% is 247.9% above this industry median. Based on the distribution chart, DocCheck AG ranks #109 out of 663 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's Operating Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DocCheck AG ranks #109 out of 663 companies for Operating Margin %. This places DocCheck AG in the top 16% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 4.86. DocCheck AG's value of 16.91% is 247.9% above this benchmark. Historically, DocCheck AG's own Operating Margin % has ranged from 5.94 to 21.17 over the past decade. While the company's 10-year median is 13.98 vs. the industry median of 4.86, DocCheck AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.86, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocCheck AG's current Operating Margin % of 16.91% is 247.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on DocCheck AG and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocCheck AG's current Operating Margin % is 16.91%, which is 21% above median its own 10-year median of 13.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (XTER:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.52, compared to a current price of €11.80 — trading 23.9% above its estimated fair value. The current Operating Margin % is 16.91%, which is 21% above median its 10-year median of 13.98 and 247.9% above the Healthcare Providers & Services industry median of 4.86. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For DocCheck AG (XTER:AJ91), the current Operating Margin % is 16.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocCheck AG (XTER:AJ91) Overvalued in 2026?
Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued.
The current stock price of €11.80 is trading 23.9% above its estimated GF Value™ of €9.52.
GuruFocus considers DocCheck AG to be Modestly Overvalued.
Key valuation signals for XTER:AJ91:
Operating Margin %: 16.91% (21% above median its 10-year median of 13.98)
GF Value™: €9.52 vs. price of €11.80 (23.9% above fair value)
Industry Position: 247.9% above the Healthcare Providers & Services median (#109 of 663)
No single metric tells the full story. See the XTER:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score
Get the complete analysis for XTER:AJ91
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AJ91 has been successfully added to your 
